Rare diseases
Investigational molecules
Locations
Back to Germany57 clinical trials in Immenhausen, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
GermanyStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
GermanyPumitamig Versus Durvalumab in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Without Progression After Chemoradiation
GermanyA study of ABBV-706 and atezolizumab for patients with previously untreated extensive stage small cell lung cancer
GermanyA study to evaluate the effectiveness of BI 1015550 in people with lung abnormalities and a family history of pulmonary fibrosis
GermanyEvaluation of mRNA-4359 Monotherapy and Combined Pembrolizumab Therapy in Advanced Solid Tumors: A Phase 1/2 Clinical Trial
GermanyTesting Treprostinil Palmitil Inhalation Powder for Improving Exercise Ability in Patients with Pulmonary Hypertension Related to Interstitial Lung Disease
GermanyA Study Comparing PF-08046054 to Docetaxel in Adults with Previously Treated PD-L1 Positive Non-Small Cell Lung Cancer
GermanyA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
GermanyA Study of BMS-986504 with Drug Combination Compared to Placebo with Drug Combination in Patients with Advanced Non-Small Cell Lung Cancer Starting First Treatment
GermanyStudy comparing GSK5764227 and topotecan in adults with relapsed small cell lung cancer
GermanyStudy comparing RMC-6236 and docetaxel in previously treated patients with advanced or metastatic non-small cell lung cancer who have RAS mutations
GermanyThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on non-small cell lung cancer (NSCLC) and its various stages, testing innovative therapies and treatment combinations. Research includes studies on metastatic disease and post-surgery treatments.
Multiple studies evaluating novel drug combinations with established treatments like pembrolizumab and chemotherapy.
Research targeting various respiratory conditions, including chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis. Studies focus on improving patient outcomes and testing new therapeutic approaches.
Investigations into new medications for managing chronic respiratory conditions and preventing disease progression.
Innovative research exploring targeted therapies and personalized treatment approaches for various lung conditions. Studies include both early-stage and advanced disease management strategies.
Focus on developing more effective and personalized treatment options for patients with various lung diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
